| Dr Angela Cartwright, DO | |
|
226 S Woods Mill Rd Ste 60, Chesterfield, MO 63017-3662 | |
| (314) 878-7333 | |
| (314) 878-7453 |
| Full Name | Dr Angela Cartwright |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 226 S Woods Mill Rd Ste 60, Chesterfield, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548252000 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2001020579 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Womens Healthcare | 0749341568 | 2 |
News Archive
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
UT Southwestern Medical Center surgeons are helping to pioneer a trend that extends the advantages and benefits of minimally invasive surgery to patients who need middle ear surgery.
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, suggests a new study in mice from the Francis Crick Institute and the Institute of Cancer Research.
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.
› Verified 3 days ago
| Entity Name | Associates In Womens Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831276674 PECOS PAC ID: 0749341568 Enrollment ID: O20081211000245 |
News Archive
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
UT Southwestern Medical Center surgeons are helping to pioneer a trend that extends the advantages and benefits of minimally invasive surgery to patients who need middle ear surgery.
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, suggests a new study in mice from the Francis Crick Institute and the Institute of Cancer Research.
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angela Cartwright, DO 226 S Woods Mill Rd Ste 60 West, Chesterfield, MO 63017-3662 Ph: (314) 878-7333 | Dr Angela Cartwright, DO 226 S Woods Mill Rd Ste 60, Chesterfield, MO 63017-3662 Ph: (314) 878-7333 |
News Archive
Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).
UT Southwestern Medical Center surgeons are helping to pioneer a trend that extends the advantages and benefits of minimally invasive surgery to patients who need middle ear surgery.
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, suggests a new study in mice from the Francis Crick Institute and the Institute of Cancer Research.
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.
University of Florida researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in people at risk for the disease.
› Verified 3 days ago
Dr. Caroline Anne Morgan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd, Suite 68 West, Chesterfield, MO 63017 Phone: 314-576-0930 Fax: 314-514-8229 | |
Dr. Stephen C Yim, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Suite 55 West, Chesterfield, MO 63017 Phone: 314-469-4440 Fax: 314-576-2346 | |
Dr. Laura Irene Moore, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 224 South Woods Mill Road, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Joe Edward Belew, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Jessica Baldetti, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd Ste 68w, Chesterfield, MO 63017 Phone: 314-205-6788 Fax: 314-590-5954 | |
Katherine A Maxson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, S5w, Chesterfield, MO 63017 Phone: 314-469-0001 | |
Marta I Pineda, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Ste 61w, Chesterfield, MO 63017 Phone: 314-205-6957 |